BlackRock Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $156M | Buy |
2,117,536
+453,194
| +27% | +$33.4M | 0.16% | 138 |
|
|
2016
Q3 | $145M | Buy |
1,664,342
+154,652
| +10% | +$13.5M | 0.15% | 158 |
|
|
2016
Q2 | $130M | Sell |
1,509,690
-346,298
| -19% | -$29.8M | 0.13% | 168 |
|
|
2016
Q1 | $148M | Buy |
1,855,988
+4,728
| +0.3% | +$376K | 0.15% | 147 |
|
|
2015
Q4 | $233M | Buy |
1,851,260
+144,624
| +8% | +$18.2M | 0.25% | 100 |
|
|
2015
Q3 | $178M | Sell |
1,706,636
-1,519,788
| -47% | -$158M | 0.19% | 124 |
|
|
2015
Q2 | $398M | Sell |
3,226,424
-182,851
| -5% | -$22.6M | 0.41% | 61 |
|
|
2015
Q1 | $402M | Buy |
3,409,275
+306,342
| +10% | +$36.1M | 0.41% | 65 |
|
|
2014
Q4 | $369M | Buy |
3,102,933
+971,254
| +46% | +$115M | 0.37% | 65 |
|
|
2014
Q3 | $239M | Buy |
2,131,679
+1,000,568
| +88% | +$112M | 0.24% | 104 |
|
|
2014
Q2 | $107M | Sell |
1,131,111
-309,045
| -21% | -$29.3M | 0.1% | 215 |
|
|
2014
Q1 | $102M | Sell |
1,440,156
-25,580
| -2% | -$1.81M | 0.1% | 222 |
|
|
2013
Q4 | $109M | Sell |
1,465,736
-90,322
| -6% | -$6.71M | 0.1% | 206 |
|
|
2013
Q3 | $118M | Buy |
1,556,058
+743,057
| +91% | +$56.3M | 0.12% | 195 |
|
|
2013
Q2 | $65.1M | Buy |
+813,001
| New | +$65.1M | 0.07% | 273 |
|